Work with thought leaders and academic experts in neurology clinical

Companies can greatly benefit from working with experts in the field of Neurology (clinical). These researchers can provide valuable insights and expertise in areas such as drug development, clinical trials, neuroimaging, neurodegenerative diseases, and neurological disorders. By collaborating with academic researchers in Neurology (clinical), companies can enhance their research and development efforts, gain access to cutting-edge technologies and methodologies, and accelerate the translation of scientific discoveries into practical applications. Additionally, these collaborations can lead to the development of new therapies, diagnostic tools, and medical devices, ultimately improving patient outcomes and advancing the field of Neurology (clinical).

Experts on NotedSource with backgrounds in neurology clinical include Ramy Ayoub, Daniel Milej, Ph.D., Tim Osswald, Jeffrey Townsend, Azeezat Azeez, Liam D. Hendrikse, Ph.D., Norman Farb, Nora S Vyas, Ph.D., K. Suzanne Scherf, Luke Connelly, Eric S. Kim, Ph.D., Abiodun Adewuya, Ramy Ayoub, Aminda J. O'Hare, Professor Sinead McGilloway, Charles T. Hill, PhD, Sun Eui Choi, Amir Manbachi, Dr. Adam W. Stivers, Ph.D., Orgul Ozturk, Maham Zain, Olivier Saulnier, Andrew Mikhail, Mehrdad Sheikhvatan, Patrick Reeson, andrea bazzani, Niko Popitsch, John Joe, and Bryan L Williams.

K. Suzanne Scherf

Associate Professor of Psychology & Neuroscience, Penn State University
Most Relevant Research Interests
Other Research Interests (40)
developmental cognitive neuroscience
vision
autism
adolescent
Cognitive Neuroscience
And 35 more
About
My core interests lie in understanding how children and adolescents perceive and interpret social signals and how emerging functional specificity of the developing brain supports this process. My approach primarily involves using the face processing system as a model domain. Faces are dynamic stimuli from which we extract many different kinds of information (e.g., gender, age, emotional state, mate potential, social status, trustworthiness, intentions, “person knowledge”). All of these processes must be executed accurately and rapidly for many faces over the course of a single day, making face processing among the most taxing perceptual challenges confronted by people in their day-to-day life. Given that faces are also the pre-eminent social signal, studying developmental changes in the behavioral and brain basis of face processing in typically developing individuals and in those affected by social-emotional disorders may index a core set of developmental changes within the broader social information processing system. I employ converging methodologies, including functional (fMRI) and structural magnetic resonance, and diffusion tensor imaging (DTI) along with detailed behavioral paradigms in both typically developing populations and those with developmental disorders to examine development from early childhood to adulthood.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (53)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 48 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Eric S. Kim, Ph.D.

Vancouver
Assistant Professor of Psychology, University of British Columbia
Most Relevant Research Interests
Other Research Interests (41)
health psychology
social epidemiology
aging
well-being
purpose & meaning
And 36 more
About
Dr. Kim's program of research aims to identify, understand, and intervene upon the dimensions of psychological well-being (sense of purpose in life, optimism) that reduce the risk of age-related conditions. <br> Around this topic, he has given invited lectures at Universities (Harvard, U. of Penn, MIT, Columbia U.), corporations (UnitedHealth Care, IDEO, AARP, Samsung), and he’s also been invited to speak at and join the working groups of national- and international-think-tanks (United Nations, OECD, Aspen Ideas Festival, Chan Zuckerberg Initiative, The Task Force for Global Health, World Government Summit, National Academy of Sciences). He’s also been recognized as one of Forbe’s 30 Under 30 in Healthcare, recipient of the American Journal of Epidemiology's Paper of the Year Award, the American Psychological Association Division 20 (Aging) Early Career Achievement Award, and an Association for Psychological Science (APS) Rising Star. His insights have been featured in the: NY Times, Atlantic, BBC News, NPR, Washington Post. His research has been cited by policy statements/guidelines formulated by the: United Nations, National Academy of Sciences, American Heart Association, the U.S. Surgeon General. Population aging is one of the most important social trends of the 21st century. In both Canada and the U.S., the # of adults aged ≥65 is projected to increase by 45%-55% in the next 15 years. As societies grapple with the rising tide of chronic conditions, healthcare costs, and long-term care costs, it is imperative to develop a science that informs a more comprehensive approach to healthy aging. Dr. Kim’s overarching goal is to substantially help improve the psychological well-being and physical health of our rapidly growing population. In pursuit of this goal, his program of research revolves around 4 interwoven questions. He studies: 1) Several dimensions of psychological well-being (sense of purpose in life, optimism) and how they relate to health outcomes. 2) The behavioral, biological, and neural mechanisms underlying the association between psychological well-being and health. 3) How an individual’s psychological well-being interacts with the surrounding environment to influence behavioral and physical health outcomes; for example, at the meso-level (dyadic dynamics in couples, neighborhood contexts, altruism/volunteering) and the macro-level (social cohesion, social and racial disparities). 4) And he partners with non-profit/healthcare companies to conduct translational research that test scalable interventions.

Professor Sinead McGilloway

Professor of Family and Community Mental Health and Founder Director of the Centre for Mental Health and Community Research (CMHCR), Maynooth University Department of Psychology (THE 2023 ranking: 126-150) and Social Sciences Institute.
Most Relevant Research Interests
Other Research Interests (40)
Education
Public Health, Environmental and Occupational Health
Health Policy
Sociology and Political Science
Social Sciences (miscellaneous)
And 35 more
About
Professor Sinead McGilloway is Professor of Family and Community Mental Health and Founder Director of the *Centre for Mental Health and Community Research* in the Maynooth University Dept of Psychology and Social Sciences Institute ([www.cmhcr.eu](http://www.cmhcr.eu/)). She is a Chartered Psychologist and Chartered Scientist with the British Psychological Society (BPS) and an Associate Fellow of the BPS. She has extensive experience in undertaking engaged policy- and practice-relevant research with a focus on child and adult mental health and well-being (incl. vulnerable/ marginalised groups), early intervention/prevention and service evaluation. She has won significant research funding to date, is widely published and has won a number of awards, including the Lionel Hersov Memorial (Team) Award by the (UK) Association for Child and Adolescent Mental Health (2022), an Irish Research Council Research Ally prize (2022) and Maynooth University Faculty of Social Sciences Research Achievement Award 2021.

Example neurology clinical projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on neurology clinical?

Drug Development for Neurological Disorders

A pharmaceutical company can collaborate with a Neurology (clinical) researcher to develop new drugs for neurological disorders such as Alzheimer's disease, Parkinson's disease, or multiple sclerosis. The researcher's expertise in understanding the underlying mechanisms of these disorders and their experience in conducting clinical trials can greatly contribute to the development of effective and safe treatments.

Neuroimaging Research

Companies in the medical imaging industry can collaborate with Neurology (clinical) researchers to advance neuroimaging techniques and technologies. By working together, they can develop new imaging modalities, improve image analysis algorithms, and explore novel applications of neuroimaging in diagnosing and monitoring neurological conditions.

Precision Medicine in Neurology

Collaborating with a Neurology (clinical) researcher can help companies in the healthcare sector to develop personalized treatment approaches for neurological disorders. By leveraging the researcher's expertise in genomics, biomarkers, and data analysis, companies can identify subtypes of neurological conditions, predict treatment responses, and tailor therapies to individual patients.

Neurological Device Innovation

Medical device companies can benefit from collaborating with Neurology (clinical) researchers to design and develop innovative devices for neurological conditions. The researcher's knowledge of neurophysiology, neuroengineering, and neurorehabilitation can contribute to the creation of advanced neurostimulation devices, brain-computer interfaces, and assistive technologies for individuals with neurological disabilities.

Clinical Trials and Outcome Measures

Companies involved in clinical research can partner with Neurology (clinical) researchers to conduct clinical trials and develop reliable outcome measures for neurological interventions. The researcher's expertise in study design, patient recruitment, and outcome assessment can ensure the successful execution of trials and the accurate evaluation of treatment efficacy.